World Hemophilia Day, an international awareness day for hemophilia and other bleeding disorders, is held annually on April 17. Hemophilia, an inherited blood disorder that affects mostly men, impairs a person’s ability to clot blood. A study led by a researcher from the McMaster Centre for Transfusion Research suggests more men have hemophilia worldwide than previously thought, highlights the need for improved hemophilia care, and helps predict demand for the plasma protein products used to treat patients.
“There’s nothing I wouldn’t have done, knowing full well it was something only we could do. At the end of the day, Canadian Blood Services got this done. A child has been treated because we were adamant we were going to provide a solution."
For patients who have cardiac surgery, the risk of severe blood loss is high if they have a condition called acquired hypofibrinogenemia — this means they have an undersupply of an essential blood clotting protein called fibrinogen. Doctors aim to minimize their bleeding with a fibrinogen replacement product, either cryoprecipitate or fibrinogen concentrate, to restore clotting factors to normal levels. A recent study that compared both products could have an impact on how cardiac patients are treated in Canada.
Do you know of an individual whose contributions might be worthy of the Canadian Blood Services Lifetime Achievement Award? To receive this honour, a nominee’s landmark contributions must be recognized as both extraordinary and world class in the field of transfusion or transplantation medicine, stem cell or cord blood research in Canada and/or abroad. Nominations are open until May 19, 2020.
The 2020 competition for one of the Centre for Innovation’s most exciting and impactful research funding programs is now open. The Intramural Research Grant Program is a long-standing program that supports research to improve the safety and efficacy of blood products and the blood system in general.
On Nov. 13, 2019, the Centre for Blood Research hosted the 13th annual Earl W. Davie Symposium in Vancouver, BC. This symposium brings together world-class researchers, eager trainees, and a giant in the world of blood coagulation – Dr. Earl W. Davie himself.
The Centre for Innovation supports research, innovation and education in key areas in blood, plasma, stem cells, and organs and tissues. This support is in part through the many competitive funding programs centre administers. These are open to Canadian researchers interested in pursuing projects focused on Canadian Blood Services priorities. Read on to learn about the recent recipients of funding through our Postdoctoral Fellowship Program and our Blood Efficiency Accelerator Award Program.
The AABB Annual Meeting is a must-attend event for those in the fields of transfusion medicine and cellular therapies. AABB 2019 took place last month in San Antonio, Texas. Canadian Blood Services trainees Dr. Narges Hadjesfandiari and Dr. Olga Mykhailova were there and report back on meeting highlights.
Drinking the blood of the young, and thereby somehow capturing their youth, is a common literary trope. The ghoulish notion speaks to our cultural fascination with youth, but also to our dread of aging. There’s no evidence-based therapy using the blood of young people to counteract or prevent the effects of aging, but young blood is an area where science might be beginning to imitate art — at least, sort of. “When we talk about young blood, we’re really talking about two streams of work,” says Dr. Jason Acker, a senior scientist at Canadian Blood Services’ Centre for Innovation and professor
Stories underlie all research experiences, but these stories are rarely told. The Centre for Innovation is excited to launch its second annual Lay Science Writing Competition and give our research trainees the chance to tell those stories!